Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Abbott Laboratories saw a big jump in demand for its diabetes products in the first quarter, which helped the medical-device ...

Diabetic kidney disease is chronic kidney disease that occurs as a complication of diabetes. Learn about its signs and ...

The maker of Ozempic and Wegovy found fake 1-milligram injections were being distributed through unauthorized sellers.

A large-scale Swedish study, recently published following over 24 years of follow-up, has found that high intakes of certain ...

Celularity (CELU) welcomes action by the Centers for Medicare & Medicaid Services, or CMS, to revise to January 1, 2026, the effective date ...

Abbott extends its long streak of earnings beats, and the stock surges to lead the S&P 500 index's gainers Abbott Laboratories saw a big jump in demand for its diabetes products in the first ...